"10.1371_journal.pone.0063172","plos one","2013-05-07T00:00:00Z","Mohsen Khademi; Ann M Dring; Jonathan D Gilthorpe; Anna Wuolikainen; Faiez Al Nimer; Robert A Harris; Magnus Andersson; Lou Brundin; Fredrik Piehl; Tomas Olsson; Anders Svenningsson","Karolinska Institute, Department of Clinical Neuroscience, Neuroimmunology Unit, Stockholm, Sweden; Ume책 University, Department of Pharmacology and Clinical Neuroscience, Ume책, Sweden; Ume책 University, Department of Chemistry, Ume책, Sweden; Karolinska University Hospital, Department of Neurology, Stockholm, Sweden","Conceived and designed the experiments: MK AMD FP TO AS. Performed the experiments: MK AMD JDG FAN RAH MA LB. Analyzed the data: AMD AW. Contributed reagents/materials/analysis tools: TO AS. Wrote the paper: MK AMD JDG FP TO AS.","AS has received travel support and/or lecture honoraria from BiogenIdec, MerckSerono, Genzyme/SanofiAventis, and Baxter, and he has received unconditional research grants from BayerScheringPharma and BiogenIdec. TO has received personal compensation for consultancy or lecture fees from BiogenIdec, MerckSerono, SanofiAventis, BayerSchering and Novartis. BiogenIdec Sweden AB provided an unrestricted grant for this study. LB has recieved teaching and consultation fees from BiogenIdec, SanofiAventis, Novartis, Genzyme and Amirall. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Mohsen Khademi","MK",11,TRUE,5,7,2,6,TRUE,FALSE,FALSE,0,NA,FALSE
